03/20/2026 | Press release | Distributed by Public on 03/20/2026 11:18
Management's Discussion and Analysis of Financial Condition and Results of Operations (dollar amounts in thousands, except share amounts, per share data, percentages, and as otherwise noted)
The following discussion and analysis should be read in conjunction with our Consolidated Financial Statements and related notes and other financial information appearing elsewhere in this Annual Report on Form 10-K. Except as otherwise specified, references to "we," "us," "our," or the "Company" refer to Lord Abbett Private Credit Fund. This discussion contains forward-looking statements, which relate to future events or the future performance or financial condition and involves numerous risks and uncertainties, including, but not limited to, those set forth in "Item 1A. - Risk Factors" and elsewhere in this Annual Report on Form 10-K. This discussion should be read in conjunction with the "Cautionary Statement Regarding Forward-Looking Statements" in this Annual Report on Form 10-K. Actual results could differ materially from those implied or expressed in any forward-looking statements.
OVERVIEW
We were formed on November 27, 2023, as a Delaware limited partnership named Lord Abbett Private Credit Fund 1, LP. On August 30, 2024, we converted to a Delaware statutory trust and were renamed Lord Abbett Private Credit Fund. We are a non-diversified, closed-end management investment company that has elected to be regulated as a BDC under the 1940 Act. We are externally managed by the Adviser, which manages our day-to-day operations and provides us with investment advisory services pursuant to the terms of the Advisory Agreement. The Adviser is registered as an investment adviser with the SEC. We elected to be treated for U.S. federal income tax purposes, and intend to qualify annually thereafter, as a RIC under Subchapter M of the Code.
The Adviser oversees (subject to the oversight of the Board, a majority of whom are Independent Trustees) the management of our operations and is responsible for making investment decisions with respect to our portfolio pursuant to the terms of the Advisory Agreement. Under the Advisory Agreement, we have agreed to pay the Adviser an annual management fee as well as an incentive fee based on our investment performance. Also, under the Administration Agreement, we have agreed to pay Lord, Abbett & Co. LLC (the "Administrator") an administration fee on a monthly basis.
Our investment objective is to generate current income and, to a lesser extent, long-term capital appreciation, by primarily focusing on directly originated, senior secured loans to U.S. middle market companies.
As a BDC, we may not acquire any asset other than assets of the type listed in Section 55(a) of the 1940 Act, which are referred to as qualifying assets, unless, at the time the acquisition is made, qualifying assets represent at least 70% of our total assets. "Qualifying assets" are generally privately offered securities issued by U.S. private companies or thinly traded public companies. We may also invest up to 30% of our portfolio opportunistically in "non-qualifying" portfolio investments, such as investments in non-U.S. companies, joint ventures or other interests that are non-qualifying. The Adviser directly originates credit opportunities from a large universe of private equity sponsors, strategic sourcing relationships, intermediaries and other direct lenders, as well as internal Lord Abbett resources.
We generally intend to distribute substantially all of our available earnings annually by paying distributions on a monthly basis, as determined by our Board, in its discretion.
KEY COMPONENTS OF OUR RESULTS OF OPERATIONS
Investments
Our level of investment activity can and does vary substantially from period to period depending on many factors, including the amount of debt available to middle-market companies, the general economic environment and the competitive environment for the type of investments we make.
Revenue
We plan to generate revenue in the form of interest and fee income on debt investments, capital gains, and dividend income from our equity investments in our portfolio companies. Our senior and subordinated debt investments are expected to bear interest at a fixed or floating rate. Interest on debt securities is generally payable quarterly or semiannually. In some cases, some of our investments may provide for deferred interest payments or PIK interest. The principal amount of the debt securities and any accrued but unpaid PIK interest generally will become due at the maturity date. In addition, we may generate revenue in the form of commitment and other fees in connection with transactions. Original issue discounts and market discounts or premiums will be capitalized, and we will accrete or amortize such amounts as interest income. We will record prepayment premiums on loans and debt securities as interest income. Dividend income, if any, will be recognized on an accrual basis to the extent that we expect to collect such amounts. In addition, we generate revenue in the form of commitment, loan origination, structuring or diligence fees, fees for providing managerial assistance to our portfolio companies, and possibly consulting fees.
Expenses
Except as specifically provided below, all investment professionals and staff of the Adviser, when and to the extent engaged in providing investment advisory services to us, and the base compensation, bonus and benefits, and the routine overhead expenses, of such personnel allocable to such services, will be provided and paid for by the Adviser. The Administrator or its affiliates will bear all fees, costs, and expenses incurred that are not assumed by the Company.
The Company will bear the following costs and expenses of the Company's operations, administration, and transactions:
| (i) | investment advisory fees, including the base management fee and incentive fee, to the Adviser, pursuant to the Advisory Agreement; |
| (ii) | Administration Fee to the Administrator, pursuant to the Administration Agreement; |
| (iii) | sub-administration fee to a sub-administrator, pursuant to a sub-administration agreement; |
| (iv) | organization and offering expenses associated with this offering (including legal, accounting, printing, mailing, subscription processing and filing fees and expenses and other offering expenses, including reasonable bona fide due diligence expenses of participating intermediaries supported by detailed and itemized invoices, fees and expenses of the Company's transfer agent); |
| (v) | all taxes, fees, costs, and expenses, retainers and/or other payments of accountants, legal counsel, advisers (including tax advisers), administrators, auditors (including with respect to any additional auditing required under The Directive 2011/61/EU of the European Parliament and of the Council of 8 June 2011 on Alternative Investment Fund Managers and any applicable legislation implemented by an EEA Member state in connection with such Directive), investment bankers, administrative agents, paying agents, depositaries, custodians, trustees, sub-custodians, consultants (including individuals consulted through expert network consulting firms), engineers, senior advisers, industry experts, operating partners, deal sourcers (including personnel dedicated to but not employed by the Administrator, or its affiliates), and other professionals (except to the extent such taxes, fees, costs, and expenses are borne by the Administrator or its affiliates under the Administration Agreement or borne by the Adviser or its affiliates under the Advisory Agreement); |
| (vi) | the cost of effecting any sales and repurchases of the Company's common shares of beneficial interest, $0.01 par value per share (the "Common Shares") and other securities; |
| (vii) | fees and expenses payable under any placement agent and selected intermediary agreements, if any; |
| (viii) | interest and fees and expenses arising out of all borrowings, guarantees and other financings or derivative transactions (including interest, fees and related legal expenses) made or entered into by the Company, including, but not limited to, the arranging thereof and related legal expenses; |
| (ix) | fees and expenses of any third-party valuation services; | |
| (x) | all fees, costs and expenses of any loan servicers and other service providers and of any custodians, lenders, investment banks and other financing sources; |
| (xi) | costs incurred in connection with the formation or maintenance of entities or vehicles to hold the Company's assets for tax or other purposes; |
| (xii) | costs of derivatives and hedging; |
| (xiii) | all fees, costs and expenses, if any, incurred by or on behalf of the Company in developing, negotiating and structuring prospective or potential investments that are not ultimately made, including, without limitation any broken deal expenses, legal, research, tax, administrative, accounting, travel, meals, accommodations and entertainment, advisory, consulting and printing expenses or other expenses associated with advisers in connection with conducting due diligence or otherwise pursuing a particular non-consummated transaction, reverse termination fees and any liquidated damages, commitment fees that become payable in connection with any proposed investment that is not ultimately made, forfeited deposits or similar payments; |
| (xiv) | the allocated costs incurred by the Adviser and the Administrator in providing (or arranging for the provision of) managerial assistance to those portfolio companies that request it; |
| (xv) | all brokerage costs, hedging costs, prime brokerage fees, custodial expenses, agent bank and other bank service fees; private placement fees, commissions, appraisal fees, commitment fees and underwriting costs; costs and expenses of any lenders, investment banks and other financing sources, and other investment costs, fees and expenses actually incurred in connection with evaluating, making, holding, settling, clearing, monitoring or disposing of actual investments (including, without limitation, travel, meals, accommodations and entertainment expenses and any expenses related to attending trade association and/or industry meetings, conferences or similar meetings, any costs or expenses relating to currency conversion in the case of investments denominated in a currency other than U.S. dollars) and expenses arising out of trade settlements (including any delayed compensation expenses); |
| (xvi) | investment costs, including all fees, costs and expenses incurred in sourcing, evaluating, developing, negotiating, structuring, trading (including trading errors), settling, monitoring and holding prospective or actual investments or investment strategies including, without limitation, any financing, legal, filing, auditing, tax, accounting, compliance, loan administration, travel, meals, accommodations and entertainment, advisory, consulting, engineering, data-related and other professional fees, costs and expenses in connection therewith (to the extent the Adviser is not reimbursed by a prospective or actual issuer of the applicable investment or other third parties or capitalized as part of the acquisition price of the transaction), or any fees, costs and expenses related to the organization or maintenance of any vehicle through which the Company directly or indirectly participates in the acquisition, holding and/or disposition of investments or which otherwise facilitate the Company's investment activities; |
| (xvii) | transfer agent, dividend agent and custodial fees; |
| (xviii) | federal and state registration fees, franchise fees, any stock exchange listing fees and fees payable to rating agencies; |
| (xix) | fees and expenses including reasonable travel, entertainment, lodging and meal expenses of, and any legal counsel or other advisers retained by, or at the discretion or for the benefit of, the Independent Trustees; |
| (xx) | costs of preparing financial statements, costs of Sarbanes-Oxley Act compliance and attestation and costs of preparing and filing reports or other documents with the SEC, Financial Industry Regulatory Authority, Commodity Futures Trading Commission and other regulatory bodies and other reporting and compliance costs, including registration and exchange listing and the costs associated with reporting and compliance obligations under the 1940 Act and any other applicable federal and state securities laws, and the compensation of professionals responsible for the foregoing (except to the extent such costs and expenses are borne by the Administrator or its affiliates under the Administration Agreement or borne by the Adviser or its affiliates under the Advisory Agreement); |
| (xxi) | all fees, costs and expenses associated with the preparation and issuance of the Company's periodic reports and related statements (e.g., financial statements and tax returns) and other internal and third-party printing (including a flat service fee), publishing (including time spent performing such printing and publishing services) and reporting-related expenses (including other notices and communications) in respect of the Company and its activities (including internal expenses, charges and/or related costs incurred, charged or specifically attributed or allocated by the Company or the Adviser or its affiliates in connection with such provision of services thereby) (except to the extent such costs and expenses are borne by the Administrator or its affiliates under the Administration Agreement or borne by the Adviser or its affiliates under the Advisory Agreement); |
| (xxii) | the costs of any reports, proxy statements or other notices to shareholders (including printing and mailing costs) and the costs of any shareholder or Trustee meetings; |
| (xxiii) | proxy voting expenses; |
| (xxiv) | costs of registration rights granted to certain investors; |
| (xxv) | any taxes and/or tax-related interest, fees or other governmental charges (including any penalties incurred where the Adviser lacks sufficient information from third parties to file a timely and complete tax return) levied against the Company and all expenses incurred in connection with any tax audit, investigation, litigation, settlement or review of the Company and the amount of any judgments, fines, remediation or settlements paid in connection therewith; |
| (xxvi) | all fees, costs and expenses of any litigation, arbitration or audit involving the Company any vehicle or its portfolio companies and the amount of any judgments, assessments fines, remediations or settlements paid in connection therewith, Trustees and officers, liability or other insurance (including costs of title insurance) and indemnification (including advancement of any fees, costs or expenses to persons entitled to indemnification) or extraordinary expense or liability relating to the affairs of the Company; |
| (xxvii) | fidelity bond, trustees and officers errors and omissions liability insurance and other insurance premiums; |
| (xxviii) | all fees, costs and expenses of winding up and liquidating the Company's assets; and |
| (xxix) | extraordinary expenses (such as litigation or indemnification). |
The Adviser and/or its affiliates advanced all of our initial organization and offering expenses. Pursuant to the Expense Support and Conditional Reimbursement Agreement we have entered into with the Adviser (the "Expense Support Agreement"), the Adviser is obligated to advance all of our Other Operating Expenses (as defined below) (including organizational and offering expenses) to the effect that such expenses do not exceed 0.70% (on an annualized basis) of the Company's NAV (the "Expense Cap"). We will be obligated to reimburse the Adviser for such advanced expenses only if certain conditions are met. See "- Expense Support and Conditional Reimbursement Agreement" below. Any reimbursements will not exceed actual expenses incurred by the Adviser and its affiliates.
From time to time, the Adviser, the Administrator or their affiliates may pay third-party providers of goods or services. We will reimburse the Adviser, the Administrator or such affiliates thereof for any such amounts paid on our behalf. From time to time, the Adviser and the Administrator may defer or waive fees and/or rights to be reimbursed for expenses. All of the foregoing expenses will ultimately be borne by our shareholders, subject to the cap on organization and offering expenses described above.
Expense Support and Conditional Reimbursement Agreement
Pursuant to the Expense Support Agreement we have entered into with the Adviser, the Adviser is obligated to advance all of our Other Operating Expenses (each, a "Required Expense Payment") to the effect that such expenses do not exceed 0.70% (on an annualized basis) of the Company's NAV. Any Required Expense Payment must be paid by the Adviser to us in any combination of cash or other immediately available funds and/or offset against amounts due from us to the Adviser or its affiliates. "Other Operating Expenses" means the Company's organizational and offering expenses, professional fees, trustee fees, administration fees, and other general and administrative expenses (including the Company's allocable portion of compensation, overhead (including rent, office equipment and utilities) and other expenses incurred by the Administrator in performing its administrative obligations under the Administration Agreement, excluding the Company's base management and incentive fees owed to the Adviser, financing fees and costs (other than upfront fees on the Company's initial credit facility), brokerage commissions, placement agent fees, costs and expenses of distributing and placing the Common Shares, extraordinary expenses and any interest expenses owed by the Company, all as determined in accordance with GAAP.
The Adviser may elect to pay, at such times as the Adviser determines, certain expenses on our behalf (each, a "Voluntary Expense Payment" and together with a Required Expense Payment, the "Expense Payments"), provided that no portion of the payment will be used to pay shareholder servicing and/or distribution fees, if any, of the Company. Any Voluntary Expense Payment that the Adviser has committed to pay must be paid by the Adviser to us in any combination of cash or other immediately available funds no later than 45 days after such commitment was made in writing, and/or offset against amounts due from us to the Adviser or its affiliates.
Following any month in which Other Operating Expenses are below the Expense Cap on an annualized basis, the Adviser may be reimbursed (a, "Required Reimbursement Payment") for any Required Expense Payment to the extent that (i) the Other Operating Expenses, inclusive of such Required Reimbursement Payment remain at or below the Expense Cap and (ii) the applicable Required Expense Payment was made no more than three (3) years prior to the Required Reimbursement Payment.
Following any calendar month in which Available Operating Funds exceed the cumulative distributions accrued to the Company's shareholders based on distributions declared with respect to record dates occurring in such calendar month (the amount of such excess being hereinafter referred to as "Excess Operating Funds"), we shall pay such Excess Operating Funds, or a portion thereof, to the Adviser until such time as all Voluntary Expense Payments made by the Adviser to the Company within three (3) years prior to the last business day of such calendar month have been reimbursed. Any payments required to be made by the Company with respect to Voluntary Expense Payments shall be referred to herein as a "Voluntary Reimbursement Payment", and together with the Required Reimbursement Payments, the "Reimbursement Payments"). "Available Operating Funds" means the sum of (i) our net investment company taxable income (including net short-term capital gains reduced by net long-term capital losses), (ii) our net capital gains (including the excess of net long-term capital gains over net short-term capital losses) and (iii) dividends and other distributions paid to us on account of investments in portfolio companies (to the extent such amounts listed in clause (iii) are not included under clauses (i) and (ii) above).
No Voluntary Reimbursement Payment for any calendar month shall be made if: (1) the Effective Rate of Distributions Per Share declared by the Company at the time of such Voluntary Reimbursement Payment is less than the Effective Rate of Distributions Per Share at the time the Expense Payment was made to which such Voluntary Reimbursement Payment relates, (2) the Company's Operating Expense Ratio at the time of such Voluntary Reimbursement Payment is greater than the Operating Expense Ratio at the time the Expense Payment was made to which such Voluntary Reimbursement Payment relates, or (3) the Company's Other Operating Expenses at the time of such Voluntary Reimbursement Payment exceeds 0.70% of the Company's NAV. "Effective Rate of Distributions Per Share" means the annualized rate (based on a 365-day year) of regular cash distributions per share exclusive of returns of capital and declared special dividends or special distributions, if any. The "Operating Expense Ratio" is calculated by dividing Operating Expenses, less organizational and offering expenses, base management and incentive fees owed to the Adviser, shareholder servicing and/or distribution fees, if any, and interest expense, by the Company's net assets. "Operating Expenses" means all of the Company's operating costs and expenses incurred, as determined in accordance with GAAP for investment companies.
The Company's obligation to make a Reimbursement Payment shall automatically become a liability of the Company on the last business day of the applicable calendar month, except to the extent the Adviser has waived its right to receive such payment for the applicable month.
The Expense Support Agreement is effective until October 4, 2026 and shall renew automatically for successive one-year terms thereafter unless either the Company or the Adviser determines to terminate it and so notifies the other party. Either the Company or the Adviser may terminate the Expense Support Agreement at any time, with or without notice, without the payment of any penalty, provided that any Expense Payments that have not been reimbursed by the Company to the Adviser will remain the obligation of the Company following any such termination, subject to the terms of the Expense Support Agreement.
The following table presents a cumulative summary of the expense payments and reimbursement payments since the Company's commencement of operations:
| For the Quarter Ended |
Required Expense Payments by Adviser |
Required Reimbursement Payments to Adviser |
Unreimbursed Expense Payments |
Reimbursement Eligibility Expiration |
||||||||||
| March 31, 2024 | 232 | - | 232 | March 31, 2027 | ||||||||||
| June 30, 2024 | 832 | - | 832 | June 30, 2027 | ||||||||||
| September 30, 2024 | 572 | - | 572 | September 30, 2027 | ||||||||||
| December 31, 2024 | 949 | - | 949 | December 31, 2027 | ||||||||||
| March 31, 2025 | 353 | - | 353 | March 31, 2028 | ||||||||||
| June 30, 2025 | 280 | - | 280 | June 30, 2028 | ||||||||||
| September 30, 2025 | 680 | - | 680 | September 30, 2028 | ||||||||||
| December 31, 2025 | 2,424 | - | 2,424 | December 31, 2028 | ||||||||||
| Total | $ | 6,322 | $ | - | $ | 6,322 | ||||||||
PORTFOLIO AND INVESTMENT ACTIVITY
Our portfolio is presented below:
|
As of December 31, 2025 |
As of December 31, 2024 |
|||||||||||||||||||||||
| Cost | Fair Value |
% of Total Investments at Fair Value |
Cost | Fair Value |
% of Total Investments at Fair Value |
|||||||||||||||||||
| First Lien Secured Debt | $ | 1,219,955 | $ | 1,217,362 | 93 | % | $ | 438,194 | $ | 439,367 | 93 | % | ||||||||||||
| Second Lien Secured Debt | 29,951 | 30,070 | 2 | - | - | - | ||||||||||||||||||
| Investments in Equity | 890 | 890 | - | (a) | - | - | - | |||||||||||||||||
| Investments in Joint Venture | 61,592 | 61,606 | 5 | 33,224 | 33,221 | 7 | ||||||||||||||||||
| Total Investments at Fair value | $ | 1,312,388 | $ | 1,309,928 | 100 | % | $ | 471,418 | $ | 472,588 | 100 | % | ||||||||||||
(a)Amount is less than 1%
Our debt portfolio displayed the following characteristics of each of our investments:
| December 31, 2025 | December 31, 2024 | |||||||
| Number of portfolio companies | 45 | 22 | ||||||
| Percentage of performing debt bearing a floating rate | 100% | 100% | ||||||
| Percentage of performing debt bearing a fixed rate | 0% | 0% | ||||||
| Percentage of our total portfolio on non-accrual | 0% | 0% | ||||||
The following table presents information concerning portfolio companies to which the Company has made loans:
| Portfolio Company Metrics(1): | ||
| Median 12-month EBITDA: | $76 million | |
| Weighted average net leverage: | 4.7x(2)(3) | |
| Weighted average loan to value: | 42%(2)(4) | |
| Weighted average interest coverage: | 2.2x(2)(5) | |
| Weighted average yield on debt investments, at cost: | 9.3%(6) |
| (1) | Amounts were derived from the most recently available financial statements provided by portfolio companies which have not been independently verified by us and may reflect a normalized or adjusted amount. Such amounts have not been independently estimated by us, and accordingly, we take no responsibility for such numbers and make no representation or warranty in respect of this information. |
| (2) | Weighted average metrics are calculated as a percentage of funded par value of debt investments. |
| (3) | Net leverage is the ratio of total senior debt minus cash divided by EBITDA and taking into account leverage through the tranche to which the Company is a lender. |
| (4) | Calculated using total senior debt minus cash divided by total enterprise value estimated by the private equity sponsor or market comparables. |
| (5) | Interest coverage for a particular portfolio company is calculated by taking EBITDA and dividing by annualized latest reported interest expense. |
| (6) | Computed as (a) the annual stated spread, plus reference rate, as applicable, plus the annual accretion of discounts, plus the annual unused fees, as applicable on debt securities divided by (b) total debt investments at par value included in such securities. Actual yields earned over the life of each investment could differ materially from the yields presented herein. |
Investment Activity
Our investment activity is presented below:
|
For the Year Ended December 31, 2025 |
For the period from February 23, 2024 (commencement of operations) to December 31, 2024 |
|||||||
| Investment Activity | ||||||||
| Investments, beginning of period | $ | 472,588 | $ | - | ||||
| New investments purchased | 1,033,137 | 586,390 | ||||||
| Investments sold or repaid | (195,696) | (115,560 | ) | |||||
| Net accretion of discount on investments | 3,511 | 312 | ||||||
| Net realized gain (loss) on investments | 18 | 276 | ||||||
| Net change in unrealized appreciation/(depreciation) | (3,630 | ) | 1,170 | |||||
| Investments, end of period | $ | 1,309,928 | $ | 472,588 | ||||
| Portfolio Companies | ||||||||
| Portfolio companies, beginning of period | 22 | - | ||||||
| Number of new investment commitments in portfolio companies | 30 | 25 | ||||||
| Number of investment commitments exited or fully repaid | 7 | 3 | ||||||
| Number of portfolio companies at period end | 45 | 22 | ||||||
| Count of investments | 46 | 23 | ||||||
| Count of industries | 22 | 15 | ||||||
CONSOLIDATED RESULTS OF OPERATIONS
The following table represents our operating results:
|
For the Year Ended December 31, 2025 |
For the period from February 23, 2024 (commencement of operations) to December 31, 2024 |
|||||||
| Total investment income | $ | 83,980 | $ | 23,634 | ||||
| Less: Net expenses | 42,785 | 12,854 | ||||||
| Net investment income before taxes | 41,195 | 10,780 | ||||||
| Net investment income after taxes | 41,195 | 10,780 | ||||||
| Net change in unrealized appreciation (depreciation) | (3,822 | ) | 1,170 | |||||
| Net realized gain (loss) | 18 | 276 | ||||||
| Net increase (decrease) in net assets resulting from operations | $ | 37,391 | $ | 12,226 | ||||
Investment Income
Increase in investment income for the year ended December 31, 2025 was driven by deployment of capital, interest income from our investments, and change in invested balance. The composition of our investment income for the year ended December 31, 2025 and for the period from February 23, 2024 (commencement of operations) to December 31, 2024 was as follows (dollars in thousands):
|
For the Year Ended December 31, 2025 |
For the period from February 23, 2024 (commencement of operations) to December 31, 2024 |
|||||||
| Investment income: | ||||||||
| Non-controlled/non-affiliated investments: | ||||||||
| Interest income | $ | 75,575 | $ | 22,719 | ||||
| Fee income | 2,499 | 637 | ||||||
| Controlled/affiliated investments: | ||||||||
| Dividend income | 5,906 | 278 | ||||||
| Total Investment Income | $ | 83,980 | $ | 23,634 | ||||
Expenses
Expenses were as follows:
|
For the Year Ended December 31, 2025 |
For the period from February 23, 2024 (commencement of operations) to December 31, 2024 |
|||||||
| Expenses: | ||||||||
| Interest expense | $ | 31,055 | $ | 12,139 | ||||
| Income incentive fees | 5,880 | 713 | ||||||
| Professional fees | 4,673 | 1,432 | ||||||
| Management fees | 3,582 | 422 | ||||||
| Other general & administrative | 579 | 246 | ||||||
| Organizational costs | - | 705 | ||||||
| Administration fees | 895 | 106 | ||||||
| Amortization of offering costs | 62 | 62 | ||||||
| Capital gains incentive fees | (34 | ) | 36 | |||||
| Total expenses | $ | 46,692 | $ | 15,861 | ||||
| Expense reimbursement | (3,737 | ) | (2,585 | ) | ||||
| Management fees waived | (170 | ) | (422 | ) | ||||
| Net expenses | $ | 42,785 | $ | 12,854 | ||||
Total expenses before expense support as of December 31, 2025, consisted primarily of interest and debt financing expenses incurred in connection with our borrowings, accounting and reporting fees, and legal. We anticipate expenses to continue to grow consistent with capital deployment and borrowings over time.
Interest and Other Financing Expenses
Interest expenses, including unused commitment fees, amortization of debt issuance costs and deferred financing costs for the year ended December 31, 2025 and for the period from February 23, 2024 (commencement of operations) to December 31, 2024, were $31,055 and $12,139, respectively. The combined weighted average interest rate (excluding unused fees and financing costs) of the aggregate borrowings outstanding for the year ended December 31, 2025 and for the period from February 23, 2024 (commencement of operations) to December 31, 2024 was 6.22% and 7.52%, respectively. For the year ended December 31, 2025, interest and other debt expenses increased, primarily driven by the increase in the size of our portfolio and corresponding increase in our debt facility usage.
Net Realized Gain (Loss) and Unrealized Gain (Loss) on Investments
Net realized gain (loss) and unrealized gain (loss) on investments were as follows:
|
For the Year Ended December 31, 2025 |
For the period from February 23, 2024 (commencement of operations) to December 31, 2024 |
|||||||
| Net realized and unrealized gain (loss) | ||||||||
| Net realized gain (loss): | ||||||||
| Non-controlled/non-affiliated investments | $ | 18 | $ | 276 | ||||
| Net change in unrealized appreciation (depreciation): | ||||||||
| Non-controlled/non-affiliated investments | (3,839 | ) | 1,173 | |||||
| Controlled/affiliated investments | 17 | (3 | ) | |||||
| Net realized and unrealized gain (loss) | $ | (3,804 | ) | $ | 1,446 | |||
For the year ended December 31, 2025 and for the period from February 23, 2024 (commencement of operations) to December 31, 2024, net change in unrealized appreciation/(depreciation) on our investments was ($3,822) and $1,170, respectively, which was primarily the result of the changes in spreads in the primary and secondary markets.
FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES
We generate cash from the net proceeds of offerings of our common shares (the "Common Shares"), net borrowings from our credit facilities and unsecured debt, and cash flows from interest and fees earned from our investments and principal repayments and proceeds from sales of our investments. We may also fund a portion of our investments through borrowings from banks and issuances of senior securities, including before we have fully invested the proceeds of any closing of our continuous private offering of our Common Shares.
Our primary use of cash is investments in portfolio companies, payments of our expenses, funding repurchases under our share repurchase program and payment of cash distributions to our shareholders. Details of our credit facilities are described in "Note 5 - Debt" to the Consolidated Financial Statements. The average debt-to-equity leverage ratio during the period 9/30/2025-12/31/2025 was approximately 1.26x. We may also, from time to time, enter into new credit facilities, increase the size of existing credit facilities or issue additional debt securities. Any such incurrence or issuance would be subject to prevailing market conditions, our liquidity requirements, contractual and regulatory restrictions and other factors.
Unregistered Sales of Equity Securities
The following table summarizes the total Common Shares issued and proceeds received from the closings of the Company's continuous private offerings that occurred for the year ended December 31, 2025:
| Date | Shares Issued | Proceeds Received | ||||||
| February 3, 2025 | 1,782,884 | $ | 45,000 | |||||
| March 3, 2025 | 849,604 | 21,410 | ||||||
| April 1, 2025 | 513,669 | 12,965 | ||||||
| May 1, 2025 | 800,756 | 20,131 | ||||||
| June 2, 2025 | 1,204,565 | 30,282 | ||||||
| July 1, 2025 | 2,073,082 | 52,138 | ||||||
| August 1, 2025 | 602,622 | 15,168 | ||||||
| September 2, 2025 | 674,414 | 16,976 | ||||||
| October 1, 2025 | 1,345,224 | 33,940 | ||||||
| November 3, 2025 | 686,881 | 17,330 | ||||||
| December 1, 2025 | 2,303,214 | 58,041 | ||||||
| Total | 12,836,915 | $ | 323,381 | |||||
The following table summarizes the total net proceeds received from capital contributions/Common Shares sold for the period from February 23, 2024 (commencement of operations) to December 31, 2024:
| Date | Net Proceeds Received | |||
| February 23, 2024 | $ | 17,000 | ||
| March 4, 2024 | (1,968 | ) | ||
| March 25, 2024 | 10,610 | |||
| May 21, 2024 | 46,200 | |||
| June 27, 2024 | 8,158 | |||
| August 16, 2024 | 17,886 | |||
| August 29, 2024 | 15,375 | |||
| September 27, 2024 | 13,750 | |||
| October 3, 2024 | 16,000 | |||
| October 31, 2024 | 28,250 | |||
| November 29, 2024 | 31,130 | |||
| Total | $ | 202,391 | ||
The following table summarizes the Company's distributions declared and payable for the year ended December 31, 2025:
| Date Declared | Record Date | Payment Date | Per Share | Total Amount | ||||||||
| January 29, 2025 | January 29, 2025 | February 25, 2025 | $ | 0.25 | $ | 2,017 | ||||||
| February 26, 2025 | February 26, 2025 | March 27, 2025 | 0.24 | 2,365 | ||||||||
| March 27, 2025 | March 27, 2025 | April 28, 2025 | 0.24 | 2,569 | ||||||||
| April 24, 2025 | April 30, 2025 | May 27, 2025 | 0.24 | 2,692 | ||||||||
| May 22, 2025 | May 30, 2025 | June 27, 2025 | 0.24 | 2,885 | ||||||||
| June 24, 2025 | June 30, 2025 | July 28, 2025 | 0.23 | 3,044 | ||||||||
| July 24, 2025 | July 31, 2025 | August 27, 2025 | 0.23 | 3,524 | ||||||||
| August 25, 2025 | August 31, 2025 | September 26, 2025 | 0.23 | 3,665 | ||||||||
| September 22, 2025 | September 30, 2025 | October 28, 2025 | 0.22 | 3,658 | ||||||||
| October 22, 2025 | October 31, 2025 | November 26, 2025 | 0.22 | 3,957 | ||||||||
| November 21, 2025 | November 30, 2025 | December 23, 2025 | 0.22 | 4,113 | ||||||||
| December 19, 2025 | December 31, 2025 | January 28, 2026 | 0.22 | 4,625 | ||||||||
| Total | $ | 39,114 | ||||||||||
The following table summarizes the Company's distributions declared and payable for the period from February 23, 2024 (commencement of operations) to December 31, 2024:
| Date Declared | Record Date | Payment Date | Per Share | Total Amount | ||||||||
| June 30, 2024 | June 30, 2024 | July 24, 2024 | N/A | (1) | $ | 1,935 | ||||||
| September 30, 2024 | September 30, 2024 | September 30, 2024 | N/A | (1) | 3,574 | |||||||
| December 26, 2024 | December 26, 2024 | December 26, 2024 | 0.69 | 5,569 | ||||||||
| Total Distributions | $ | 11,078 | ||||||||||
| (1) | Prior to the Conversion Date, the Company had no shares outstanding. |
Dividend Reinvestment Plan
Shareholders of Common Shares, whose Common Shares are registered with State Street Bank and Trust Company (the "Agent"), will automatically be enrolled (the "Participants") in the Company's Dividend Reinvestment Plan (the "DRIP"). The Company will declare its income dividends or capital gains or other distributions ("Distributions") payable in Common Shares, or, at the option of shareholders, in cash. Therefore, each Participant will have all Distributions, net of any applicable U.S. withholding taxes, on his or her Common Shares automatically reinvested (net of applicable withholding tax) in additional Shares, unless such Participant elects to receive such Distributions in cash by contacting the Agent. An election to receive cash may be revoked or reinstated at the election of the shareholder. On the payment date for a Distribution, the Agent shall receive newly issued Common Shares ("Additional Shares"), including fractions, from the Company for each Participant's account. The number of Additional Common Shares to be credited shall be determined by dividing the dollar amount of the Distribution by the net asset value per Share on the payment date. The net asset value per Share on a particular date shall be the amount calculated on that date (or if not calculated on such date, the amount most recently calculated) by or on behalf of the Company in accordance with the Company's current private placement memorandum. It is contemplated that the Company will pay dividends at least quarterly. If, for any reason beyond the control of the Agent, reinvestment of the Distributions cannot be completed within thirty (30) days after the applicable payment date for such Distribution, funds held by the Agent on behalf of a Participant will be distributed to that Participant.
The following table summarizes the amounts received and Common Shares issued to shareholders who have participated in the DRIP for the year ended December 31, 2025:
| Payment Date | DRIP Shares Issued | Amount per share | DRIP Shares Value | |||||||||||||
| April 28, 2025 | 343 | $ | 25.24 | $ | 9 | |||||||||||
| May 27, 2025 | 1,195 | 25.14 | 30 | |||||||||||||
| June 27, 2025 | 8,726 | 25.14 | 219 | |||||||||||||
| July 28, 2025 | 13,997 | 25.15 | 352 | |||||||||||||
| August 27, 2025 | 14,065 | 25.17 | 354 | |||||||||||||
| September 26, 2025 | 16,068 | 25.17 | 404 | |||||||||||||
| October 28, 2025 | 16,487 | 25.23 | 416 | |||||||||||||
| November 26, 2025 | 19,939 | 25.23 | 503 | |||||||||||||
| December 23, 2025 | 22,343 | 25.20 | 563 | |||||||||||||
| 113,163 | $ | 2,850 | ||||||||||||||
Share Repurchase Program
The Company commenced a share repurchase program in which it intends to repurchase up to 5% of the Common Shares outstanding as of the close of the previous calendar quarter, at the discretion of the Board. The Board may amend, suspend or terminate the share repurchase program if in its reasonable judgment it deems such action to be in the Company's best interest and the best interest of our shareholders. As a result, share repurchases may not be available each quarter. Should the Board suspend the share repurchase program, the Board will consider whether the continued suspension of the program is in the best interests of the Company and its shareholders on a quarterly basis. However, the Board is not required to authorize the recommencement of the share repurchase program within any specified period of time. The Company intends to conduct such repurchase offers in accordance with the requirements of Rule 13e-4 promulgated under the Exchange Act. All shares purchased by the Company pursuant to the terms of each tender offer will be retired and thereafter will be authorized and unissued shares.
On August 1, 2025, under the Company's share repurchase program, the Company made a tender offer to purchase up to 600,977.8516 Common Shares, which represents approximately 5% of the Company's outstanding shares as of May 31, 2025. The tender offer was for cash at a price equal to the net asset value per share as of September 30, 2025. The offer expired at 11:59 P.M., Eastern Time, on August 29, 2025. No shares were validly tendered prior to the expiration of the offer.
On October 29, 2025, under the Company's share repurchase program, the Company made a tender offer to purchase up to 796,830.71 Common Shares, which represents approximately 5% of the Company's outstanding shares as of August 31, 2025. The tender offer was for cash at a price equal to the net asset value per share as of December 31, 2025. The offer expired at 11:59 P.M., Eastern Time, on November 28, 2025. No shares were validly tendered prior to the expiration of the offer.
Debt
The Company's outstanding debt obligations were as follows:
| As of December 31, 2025 | ||||||||||||||||
|
Aggregate Principal Committed |
Outstanding Principal |
Less Unamortized Deferred Financing Cost |
Carrying Value per Consolidated Statement of Assets and Liabilities |
|||||||||||||
| SMBC Revolving Credit Facility | $ | 325,000 | $ | 226,248 | (1) | $ | 2,879 | $ | 223,369 | |||||||
| BofA ABL Credit Facility | 450,000 | 406,300 | 2,298 | 404,002 | ||||||||||||
| RBC ABL Credit Facility | 300,000 | 170,402 | (2) | 723 | 169,679 | |||||||||||
| Total | $ | 1,075,000 | $ | 802,950 | $ | 5,900 | $ | 797,050 | ||||||||
| (1) | Net of ($71) in unrealized depreciation related to foreign currency translations |
| (2) | Net of ($123) in unrealized depreciation related to foreign currency translations |
| As of December 31, 2024 | ||||||||||||||||
|
Aggregate Principal Committed |
Outstanding Principal |
Less Unamortized Deferred Financing Cost |
Carrying Value per Consolidated Statement of Assets and Liabilities |
|||||||||||||
| BofA ABL Credit Facility | $ | 300,000 | $ | 235,882 | $ | 309 | $ | 235,573 | ||||||||
| SMBC Revolving Credit Facility | 300,000 | 150,000 | 3,343 | 146,657 | ||||||||||||
| Total | $ | 600,000 | $ | 385,882 | $ | 3,652 | $ | 382,230 | ||||||||
For further details, see "Note 5 - Debt" to our Consolidated Financial Statements included in this Annual Report on Form 10-K.
RECENT DEVELOPMENTS
Refer to Item 8. Consolidated Financial Statements "Note 10 - Subsequent Events" to our Consolidated Financial Statements included in this Annual Report on Form 10-K.
OFF-BALANCE SHEET ARRANGEMENTS
Other than contractual commitments and other legal contingencies incurred in the normal course of our business, we do not expect to have any off-balance sheet financings or liabilities. We will engage in certain transactions that may receive off-balance sheet accounting treatment, including joint venture transactions. On April 23, 2024, we entered into a limited liability company agreement with Stifel Bank & Trust ("Stifel") to establish a joint venture to make certain loans consisting of primarily middle market club loans and direct lending loans to U.S. issuers. The joint venture is called SBLA Private Credit LLC ("SBLA JV"). All portfolio decisions and generally all other decisions in respect of SBLA JV must be approved by the board of SBLA JV consisting of representatives of the Company and Stifel (generally with approval from a representative of each required). We and Stifel have equal voting rights with respect to the joint venture. The Company does not consolidate the SBLA JV. We may enter into additional joint venture agreements in the future.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
The preparation of the consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Changes in the economic environment, financial markets, and any other parameters used in determining such estimates could cause actual results to differ. Our critical accounting policies should be read in connection with our risk factors described in "Item 1A. Risk Factors." See "Item 8. Consolidated Financial Statements and Supplementary Data-Notes to Consolidated Financial Statements-Note 2. Significant Accounting Policies" of our Annual Report on Form 10-K for the year ended December 31, 2025.
Valuation of Portfolio investments
The Company is required to report its investments for which current market values are not readily available at fair value. The Company values its investments in accordance with Rule 2a-5 under the 1940 Act and FASB ASC 820, Fair Value Measurement ("ASC 820"), which defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the applicable measurement date. ASC 820 prioritizes the use of observable market prices derived from such prices over entity-specific inputs. Due to the inherent uncertainties of valuation, certain estimated fair values may differ significantly from the values that would have been realized had a ready market for these investments existed, and these differences could be material.
We expect to determine our NAV for our Common Shares each month as of the last day of each calendar month. The NAV per share of our Common Shares is determined by dividing the value of total assets minus liabilities by the total number of Common Shares outstanding at the date as of which the determination is made.
The Company values its investments, upon which its NAV is based, in accordance with ASC 820, which defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 also provides a framework for measuring fair value, establishes a fair value hierarchy based on the observability of inputs used to measure fair value and prescribes disclosure requirements for fair value measurements.
Pursuant to Rule 2a-5, the Board has designated the Adviser as the valuation designee responsible for valuing all of the Company's investments, including making fair valuation determinations as needed. The Adviser has established a fair value committee (the "Fair Value Committee") to carry out the day-to-day fair valuation responsibilities and has adopted policies and procedures to govern activities of the Fair Value Committee and the performance of functions required to determine the fair value of a fund's investments in good faith.
These functions include periodically assessing and managing material risks associated with fair value determinations, selecting, applying, reviewing, and testing fair value methodologies, monitoring for circumstances that may necessitate the use of fair value, and overseeing and evaluating pricing services used.
In accordance with the Adviser's policies and procedures, which have been approved by the Board, investments, including debt securities, that are publicly traded but for which no readily available market quotations exist are generally valued on the basis of information furnished by an independent third-party pricing service that uses a valuation matrix which incorporates both dealer-supplied valuations and electronic data processing techniques. To assess the continuing appropriateness of pricing sources and methodologies, the Adviser regularly performs price verification procedures and issues challenges as necessary to independent pricing services or brokers, and any differences are reviewed in accordance with the valuation procedures. The Adviser does not adjust the prices unless it has a reason to believe market quotations or prices received from third-party pricing services are not reflective of the fair value of an investment. Investments that are not publicly traded or whose current market prices or quotations are not readily available, as will be the case for a substantial portion of the Company's investments, are valued at fair value as determined by the Adviser in good faith pursuant to the Adviser's Board-approved policies and procedures. Factors used in determining fair value vary by investment type and may include market or investment specific events, transaction data, estimated cash flows, and market observations of comparable investments. In determining fair value of the Company's loan investments, the types of factors that the Fair Value Committee may take into account generally include comparison to publicly-traded securities including such factors as yield, maturity and measures of credit quality, the enterprise value of the portfolio company, the nature and realizable value of any collateral, the portfolio company's ability to make payments and its earnings and discounted cash flows, the markets in which the portfolio company does business and other relevant factors.
The Company has engaged an independent valuation firm to prepare month-end valuation recommendations for which market quotations are not readily available as of the last calendar day of each month. The independent valuation firm undertakes a full analysis of the investments and provides estimated fair values for such investments to the Adviser. The independent valuation firm also provides analyses to support their valuation methodology and calculations. The Adviser's Fair Value Committee reviews and approves each valuation recommendation and confirms it has been calculated in accordance with the Board-approved policies and procedures. The Fair Value Committee manages the Company's fair valuation practices and maintains the fair valuation policies and procedures. The Adviser reports to the Board information regarding the fair valuation process and related material matters. The Board may determine to modify its designation of the Adviser as valuation designee, relating to any or all Company investments, at any time.
Valuation techniques used to value the Company's investments by major category are as follows:
| • | Equity securities and other investments, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price (in the case of securities and futures) or the mean of the closing bid and offer (in the case of options) as reported by a third-party pricing service on the primary market or exchange on which they are traded. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used. |
| • | Debt securities that are publicly traded, including restricted securities, are valued based on evaluated prices received from third party pricing services or from brokers who make markets in such securities. Preferred securities are valued by pricing services who utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type or by broker-supplied prices. When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing services. |
| • | Investments in open-end investment companies are valued at their closing NAV. |
| • | Investments, including private placements, for which observable inputs are not available are generally valued using one or more valuation methods including the market approach, the income approach and cost approach. The market approach considers factors including the price of recent investments in the same or a similar security or financial metrics of comparable securities. The income approach considers factors including expected future cash flows, security specific risks and corresponding discount rates. The cost approach considers factors including the value of the security's underlying assets and liabilities. |
CONTRACTUAL OBLIGATIONS
We have entered into the Advisory Agreement with the Adviser to provide us with investment advisory services and the Administration Agreement with the Administrator to provide us with administrative services. Payments for investment advisory services under the Advisory Agreements and payment for administration services under the Administration Agreement are described in "Item 1. Business - Management Agreements."
We currently have one facility, and each of our wholly-owned subsidiaries, PCF Financing LLC and PCF Financing 2 LLC, has a credit facility. We or our wholly-owned subsidiaries may establish more credit facilities or enter into other financing arrangements to facilitate investments and the timely payment of our expenses. It is anticipated that any such credit facilities will bear interest at floating rates at to-be-determined spreads over SOFR (or other applicable reference rate). We cannot assure shareholders that we will be able to enter into a credit facility on favorable terms. In connection with a credit facility or other borrowings, lenders may require us to pledge assets, commitments and/or drawdowns (and the ability to enforce the payment thereof) and may ask to comply with affirmative or negative covenants that could have an effect on our operations.
RELATED PARTY TRANSACTIONS
We have entered into a number of business relationships with affiliated or related parties, including the following:
| • | the Advisory Agreement | |
| • | the Administration Agreement; and | |
| • | the Expense Support Agreement |
In addition to the aforementioned agreements, the SEC has granted an exemptive order (the "Order") that permits the Adviser, among other things, to co-invest our assets with the assets of certain other persons in negotiated transactions, including certain affiliates of the Adviser and certain funds managed and controlled by the Adviser and its affiliates. Co-investment under the Order is subject to certain conditions therein, including the condition that, in the case of each co-investment transaction, the Board of Trustees determines that it would be in the Company's best interest to participate in the transaction. Neither we nor the affiliated funds are obligated to invest or co-invest when investment opportunities are referred to us or them.
See Item 8. Consolidated Financial Statements "Note 3 - Related Party Transactions" to the consolidated financial statements for information on the Company's related party transactions.